Upgrade to SI Premium - Free Trial

Ensysce Biosciences (ENSC)

0.26 +0.01 (4.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/19/26)

Latest Headlines

Form S-3 Ensysce Biosciences, June 4, 2026 4:43 PM - SEC Filing Form 8-K Ensysce Biosciences, For: May 22 May 22, 2026 4:55 PM - SEC Filing Form 10-Q Ensysce Biosciences, For: Mar 31 May 15, 2026 4:27 PM - SEC Filing Form 8-K Ensysce Biosciences, For: May 15 May 15, 2026 4:27 PM - SEC Filing Ensysce Biosciences Reports First Quarter 2026 Financial Results May 15, 2026 4:15 PM - StreetInsider Ensysce Biosciences receives Taiwan patent for overdose protection technology May 12, 2026 8:09 AM - StreetInsider Ensysce Biosciences Announces Expansion of Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology May 12, 2026 8:08 AM - StreetInsider Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam May 8, 2026 8:06 AM - StreetInsider Form S-8 Ensysce Biosciences, April 30, 2026 4:22 PM - SEC Filing Ensysce receives approval for final phase of opioid overdose study April 16, 2026 8:04 AM - StreetInsider Ensysce Biosciences Secures IRB Approval of Final Phase of PF614-MPAR-102 Clinical Study April 16, 2026 8:00 AM - StreetInsider Form EFFECT Ensysce Biosciences, April 16, 2026 6:06 AM - SEC Filing Ensysce Biosciences (ENSC) files for 20.34M share offering by selling stockholders April 9, 2026 6:13 AM - StreetInsider Form S-3 Ensysce Biosciences, April 9, 2026 6:05 AM - SEC Filing Form 8-K Ensysce Biosciences, For: Apr 07 April 8, 2026 6:05 AM - SEC Filing Ensysce Biosciences closes $2 million financing tranche April 7, 2026 8:17 AM - StreetInsider Ensysce Biosciences Secures Second Financing From 2025 Agreement to Advance Breakthrough Pain Programs April 7, 2026 8:14 AM - StreetInsider Form 8-K Ensysce Biosciences, For: Apr 03 April 3, 2026 4:15 PM - SEC Filing Ensysce Biosciences (ENSC) Misses Q4 EPS by 75c March 31, 2026 6:51 AM - StreetInsider Form 10-K Ensysce Biosciences, For: Dec 31 March 30, 2026 5:49 PM - SEC Filing Form 8-K Ensysce Biosciences, For: Mar 30 March 30, 2026 5:46 PM - SEC Filing Ensysce Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results March 30, 2026 4:51 PM - StreetInsider Form 8-K Ensysce Biosciences, For: Mar 27 March 30, 2026 6:02 AM - SEC Filing Form 8-K Ensysce Biosciences, For: Mar 23 March 23, 2026 8:01 AM - SEC Filing Full Article List